Pancreatic Cancer Research

ResearcherLouisiana State UniversityActive in the last 2 years

Quyen D. Chu

Matched on ORCID iD 0000-0003-3289-0311; OpenAlex author ID A5073696926. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2012: 1 paper · 2013: 2 papers · 2014: 2 papers · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper

Papers 10

  1. Medicaid Expansion Increases Access for Rural and Impoverished Patients with Pancreatic Ductal Adenocarcinoma in Southern States. Last author DOI 10.1245/s10434-024-15039-9↗
  2. Social determinants of health associated with poor outcome for rural patients following resected pancreatic cancer. Co-author DOI 10.21037/jgo-20-583↗
  3. Treatment at a high-volume academic research program mitigates racial disparities in pancreatic adenocarcinoma. Co-author DOI 10.21037/jgo-20-584↗
  4. Accuracy and Clinical Implications of Preoperative Multidetector CT (MDCT) in Predicting Outcome and Resectability in Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.1177/000313481908500516↗
  5. Influence of facility type on survival outcomes after pancreatectomy for pancreatic adenocarcinoma. Co-author DOI 10.1016/j.hpb.2017.04.017↗
  6. Curative resection of pancreatic adenocarcinoma with major venous resection/repair is safe procedure but will not improve survival. Co-author DOI 10.6092/1590-8577/2430↗
  7. Peripancreatic soft tissue involvement: independent outcome predictor in patients with resected pancreatic adenocarcinoma. Co-author DOI 10.9738/intsurg-d-13-00112.1↗
  8. Immunocompetent orthotopic pancreatic cancer murine model: a step in the right direction. Co-author DOI 10.1016/j.jss.2011.11.1011↗
  9. Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19-9 levels in detecting recurrent pancreatic adenoc… Co-author DOI 10.6092/1590-8577/1529↗
  10. Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model. Co-author DOI 10.1016/j.surg.2012.05.040↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiao‐Cheng Wu · 4 shared papers, 2017–2024 · strength 0.70
  2. Mei‐Chin Hsieh · 3 shared papers, 2021–2024 · strength 0.62
  3. Gazi B. Zibari · 5 shared papers, 2013–2019 · strength 0.32
  4. Hosein M. Shokouh-Amiri · 5 shared papers, 2013–2019 · strength 0.32
  5. Hemanth Venkatesh · 1 shared paper, 2024 · strength 0.24
  6. Alireza Hamidian Jahromi · 4 shared papers, 2013–2019 · strength 0.24
  7. David H. Ballard · 1 shared paper, 2019 · strength 0.11
  8. Roger H. Kim · 2 shared papers, 2012–2013 · strength 0.11
  9. James Michael Mathis · 1 shared paper, 2012 · strength 0.03
  10. David Terry Curiel · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.